7.13
price down icon3.13%   -0.23
pre-market  Pre-mercato:  7.08   -0.05   -0.70%
loading

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

pulisher
Apr 18, 2025

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter - usrecallnews.com

Apr 18, 2025
pulisher
Apr 17, 2025

Even though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 years - Yahoo Finance

Apr 17, 2025
pulisher
Apr 15, 2025

Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey

Apr 15, 2025
pulisher
Apr 15, 2025

Lobbying Update: $60,000 of AMNEAL PHARMACEUTICALS INC. lobbying was just disclosed - Nasdaq

Apr 15, 2025
pulisher
Apr 14, 2025

10 Best Pharma Stocks to Buy for Long Term Growth - Insider Monkey

Apr 14, 2025
pulisher
Apr 14, 2025

Amneal donates $1.5M this Parkinson’s Awareness Month - NJBIZ

Apr 14, 2025
pulisher
Apr 14, 2025

NY AG reaches $270M multistate opioid settlement with Amneal Pharmaceuticals - Class Action Lawsuits

Apr 14, 2025
pulisher
Apr 11, 2025

Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month - BioSpace

Apr 11, 2025
pulisher
Apr 11, 2025

Amneal's $1.5M Donation Makes Parkinson's Medications More Accessible for Thousands - Stock Titan

Apr 11, 2025
pulisher
Apr 08, 2025

Amneal to Report First Quarter 2025 Results on May 2, 2025 - Bluefield Daily Telegraph

Apr 08, 2025
pulisher
Apr 08, 2025

Amneal Boruzu Subcutaneous Formulation Launch - Clinical Oncology News

Apr 08, 2025
pulisher
Apr 08, 2025

Amneal Earnings Preview: Key Updates Coming May 2 in Q1 2025 Report - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

Amneal’s CREXONT improves sleep in Parkinson’s patients By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease - BioSpace

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal Announces New Data From Phase 3 Study - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal’s CREXONT improves sleep in Parkinson’s patients - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Breakthrough: New Parkinson's Drug Shows Major Sleep Quality Gains in Phase 3 Trial - Stock Titan

Apr 07, 2025
pulisher
Apr 03, 2025

Amneal Pharmaceuticals (AMRX) Expands Coverage for Parkinson's D - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S. - BioSpace

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal gets expanded coverage for Parkinson’s disease drug - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal Announces Expanded Coverage For Crexont® To Enhance Access For Parkinson'S Disease Patients In The U.S. - marketscreener.com

Apr 03, 2025
pulisher
Apr 03, 2025

Breakthrough: Amneal's Parkinson's Drug CREXONT Secures Game-Changing Insurance Coverage - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Amneal and Shilpa introduce Boruzu in US for cancer treatment - Yahoo Finance

Apr 02, 2025
pulisher
Apr 01, 2025

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - The Joplin Globe

Apr 01, 2025
pulisher
Apr 01, 2025

Amneal Launches BORUZU , First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - Business Wire

Apr 01, 2025
pulisher
Apr 01, 2025

Groundbreaking Cancer Treatment: First Ready-Made Bortezomib Injection Hits Market - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk) - Business Wire

Mar 31, 2025
pulisher
Mar 27, 2025

Myasthenia Gravis Treatment Market Size, Growth Analysis 2031 - openPR

Mar 27, 2025
pulisher
Mar 25, 2025

Insiders At Amneal Pharmaceuticals Sold US$48m In Stock, Alluding To Potential Weakness - simplywall.st

Mar 25, 2025
pulisher
Mar 21, 2025

Amneal Digs Deeper Into GLP-1 Aspirations Following Metsera’s IPO - insights.citeline.com

Mar 21, 2025
pulisher
Mar 19, 2025

Amneal Pharmaceuticals: Shares Still Feel Significantly Undervalued (NASDAQ:AMRX) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 17, 2025

Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment - Markets Insider

Mar 17, 2025
pulisher
Mar 12, 2025

Amneal Pharmaceuticals’ SWOT analysis: generic drug maker’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Amneal Pharmaceuticals’ SWOT analysis: generic drug maker’s stock poised for growth - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Amneal at Barclays Healthcare Conference: Growth and Innovation Insights By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Amneal to Participate at Upcoming March 2025 Investor Conference - BioSpace

Mar 11, 2025
pulisher
Mar 10, 2025

Amneal to Participate at Upcoming Investor Conference - WICZ

Mar 10, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals EVP Jason Daly sells $792,159 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals CFO Tasos Konidaris sells $891,000 in stock By Investing.com - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals EVP Andrew Boyer sells $1.1 million in stock By Investing.com - Investing.com Canada

Mar 08, 2025
pulisher
Mar 07, 2025

Insider Exodus: Amneal Pharmaceuticals Executives and Directors Offload Massive Stock Holdings - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals EVP Jason Daly sells $792,159 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Teva denied stay in Amneal patent dispute as it appeals to Supreme Court - MLex

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals EVP Andrew Boyer sells $1.1 million in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals CFO Tasos Konidaris sells $891,000 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals director Alva Emily Peterson sells $712,000 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals Executives and Director Sell Shares - TradingView

Mar 07, 2025
$8.48
price up icon 0.47%
$27.00
price up icon 0.00%
$100.62
price down icon 0.69%
$7.57
price up icon 0.13%
$100.68
price down icon 0.69%
$284.25
price down icon 0.17%
Capitalizzazione:     |  Volume (24 ore):